Daily non-political popular news in brief.

Does Stimulant Treatment for ADHD Increase Risk of Drug Abuse?

06-18-2007 · Brookhaven National Laboratory

Parents, doctors, and others have wondered whether common treatments for attention-deficit hyperactivity disorder (ADHD) inadvertently predispose adolescents to future drug abuse. The answer may depend on the age at which treatment is started and how long it lasts, say the authors of a new brain-imaging and behavioral study conducted in animals at Brookhaven National Laboratory.

Keywords: stimulant, treatment, adhd, risk, drug, abuse

« Previous | Next »

Similar news on "Does Stimulant Treatment for ADHD Increase Risk of Drug Abuse?":

Mayo Clinic study indicates medication for ADHD may help student outcomes
09-18-2007 · EurekAlert!
In an 18-year-study on attention-deficit/hyperactivity disorder, Mayo Clinic researchers found that treatment with prescription stimulants is associated with improved long-term academic success of children with ADHD. The Mayo Clinic results are the first population-based data to show stimulant drug therapy helps improve long-term school outcomes.
Similar news · Read more »
OPICAN study in seven Canadian cities reveals prescription opioid abuse more prevalent than heroin
11-20-2006 · EurekAlert!
A new study conducted in seven Canadian cities reveals that prescription opioids, and not heroin, are the major form of illicit opioid use. These findings raise questions about the current focus of Canada's drug control policy and treatment programs.
Similar news · Read more »
Improvement following ADHD treatment sustained in most children
07-20-2007 · EurekAlert!
Most children treated in a variety of ways for Attention Deficit Hyperactivity Disorder showed sustained improvement after three years, in a major follow-up study. Yet increased risk for behavioral problems, including delinquency and substance use, remained higher than normal. Initial advantages of medication management alone or in combination with behavioral treatment over purely behavioral or routine community care waned in the years after 14 months of controlled treatment ended.
Similar news · Read more »
Stimulant Inaction: ADHD drug's mental lift proves surprisingly weak
11-03-2007 · Science News Online
A widely used drug often calms children with attention-deficit hyperactivity disorder but does little to alleviate the condition's underlying mental deficits.
Similar news · Read more »
Radiation therapy reduces cancer recurrence in older breast cancer patients
01-22-2007 · EurekAlert!
Radiation therapy after lumpectomy and five years of treatment with the drug tamoxifen can dramatically reduce the risk of both cancer recurrence and new tumors in older women with early breast cancer, according to researchers from Wake Forest University School of Medicine and colleagues.
Similar news · Read more »
Plays promote prevention of drug abuse
04-04-2007 · EurekAlert!
A new study finds that theatrical drama is an educational tool in the fight against drug addiction and abuse. Research published today in Substance Abuse Treatment, Prevention and Policy, shows that after watching the play "Tunnels" -- a series of six vignettes depicting the effects of alcohol and drug abuse -- over half of the audience left the theatre wanting to get involved directly in drug and alcohol prevention in their homes and communities.
Similar news · Read more »
Genes play important role in risk for dependence on illicit and licit drugs
11-05-2007 · EurekAlert!
The genes that play a role in illegal drug abuse are not entirely the same as those involved in dependence on legal substances like alcohol and nicotine, and caffeine addiction appears to be genetically independent of all the others, according to a study led by Virginia Commonwealth University researchers.
Similar news · Read more »
HIV drug resistance risk in mothers reduced by combination of common drugs
11-09-2007 · EurekAlert!
Adding a single dose of two common anti-HIV drugs can prevent HIV-positive pregnant women from developing resistance to an entire class of drugs, potentially improving future treatment options.Providing tenofovir and emtricitabine with nevirapine during labor greatly reduces the extent of resistance to non-nucleoside reverse transcriptate inhibitors, such as nevirapine, which HIV-positive women take to lower the risk of mother-to-child transmission during childbirth.
Similar news · Read more »
Promising treatment for post traumatic stress disorder sleep disturbances
04-17-2007 · EurekAlert!
For sufferers of post traumatic stress disorder, sleep disturbances are among the most treatment-resistant symptoms and can lead to drug and alcohol abuse and even suicide. Previously, there has been little success in treating these sleep disorders with psychopharmacologic approaches. In a study in the April 15 issue of Biological Psychiatry, researchers have found that an inexpensive, widely available drug was successful in reducing symptoms in chronic PTSD patients.
Similar news · Read more »
Scientists demonstate link between genetic variant and effectiveness of smoking cessation meds
09-10-2007 · EurekAlert!
A genetic variant present in nearly half of Americans of European ancestry is linked to greater effectiveness of the smoking cessation medication bupropion (Zyban), according to research by scientists supported by the National Institute on Drug Abuse and the National Cancer Institute, part of the National Institutes of Health. People with this variant were less likely than those without it to have resumed smoking six months after treatment with bupropion.
Similar news · Read more »